Calcyclin-binding protein/Siah-1 -interacting protein (CacyBP/SIP), a target protein of the S100 family, which includes S100A6, S100A1, S100A12, S100B, and S100P, has been identified as a component of a novel ubiquitinylation complex leading to B-catenin degradation. However, the function of CacyBP/SIP in gastric cancer has not been elucidated. In the present study, we prepared CacyBP/SIP overexpressing and knockdown cell lines of gastric cancer. Forced CacyBP/SIP expression inhibited the proliferation of gastric cancer cells, suppressed tumorigenicity in vitro, and prolonged the survival time of tumor-bearing nude mice. In addition, increased CacyBP/SIP repressed the invasive potential of gastric cancer cells. Conversely, the down-regulation of CacyBP/SIP by RNA interference showed the opposite effects. Further studies showed that depressed CacyBP/SIP increased the expression of total and nuclear B-catenin at the protein level and elevated the transcriptional activity of Tcf/LEF. Taken together, our results suggest that CacyBP/SIP may be a potential inhibitor of cell growth and invasion in the gastric cancer cell, at least in part through the effect on B-catenin protein expression and transcriptional activation of Tcf/LEF.
Introduction
Calcyclin-binding protein (CacyBP), a 30 kDa protein, was identified on the basis of its ability to interact with S100 proteins, including S100A6, S100A1, S100A12, S100B, and S100P, in a calcium-dependent manner (1) (2) (3) . CacyBP/SIP is highly expressed in the mouse and in rat brain, liver, spleen, and stomach, and weakly in rat lung and kidney (4) . Recent studies have suggested that CacyBP/SIP is implicated in the differentiation of erythroid cells, neurons, and rat neonatal cardiomyocytes (5) , the development of thymocytes (6) , and in mouse endometrial events, such as the establishment of pregnancy (7) . It has been reported that the expression and translocation of CacyBP/SIP has been observed in neuroblastoma NB-2a cells (8) . A human orthologue of CacyBP, Siah-1 -interacting protein (SIP), has been shown to be a component of the novel ubiquitin ligase complex responsible for ubiquitination and degradation of h-catenin (9, 10), which is known to be an oncogene participating in tumorigenesis in many different types of cancers (11, 12) . Like h-catenin, many target proteins of Siah-1 -mediated degradation have been reported, including DCC (13) , N-CoR (14) , PHD1/3 (15) , and proto-oncogene c-Myb (16) . This suggests that CacyBP/SIP may play a role in tumorigenesis by participating in the degradation of cancerrelated proteins. However, the pathologic roles of human CacyBP/SIP remain unclear. The aim of this study was to explore the role of CacyBP/SIP in tumorigenesis of gastric cancer and the related mechanism. In the present study, we observed the effects of ectopic expression and knockdown of CacyBP/SIP on cell proliferation and invasion of gastric cancer cells in vitro and in vivo. Expression and distribution of h-catenin was further examined by Western blot analysis and immunofluorescence staining; Tcf/LEF transcriptional activation was also detected by the reporter gene assay. These results showed that overexpressed CacyBP/SIP inhibits proliferation, tumorigenicity, and invasion of gastric cancer cells, at least in part, via the down-regulation of h-catenin and the consequent transcriptional activation of Tcf/LEF.
Results

Analysis of CacyBP/SIP Expression in Gastric Cancer Cells
The levels of expression of CacyBP/SIP mRNA and protein in gastric cancer cell lines were examined by semiquantitative reverse transcription-PCR (RT-PCR) and Western blot analysis. As shown in Fig. 1 , both the mRNA and protein of CacyBP/SIP were expressed at higher levels in the well-differentiated gastric cancer cell line, MKN28, and was somewhat lower in the moderately differentiated gastric cancer cell line, SGC7901 (P < 0.001). The lowest expressions of CacyBP/SIP mRNA and protein were observed in the poorly differentiated gastric cancer cell lines, KATOIII, MKN45, MGC803, and AGS.
The Expression of CacyBP/SIP in Sense and Short Interfering RNA Transfectants
To investigate whether CacyBP/SIP affected the growth and proliferation of gastric cancer cells, we selected the SGC7901 cell line, which moderately expresses CacyBP/SIP, as a model and introduced the CacyBP/SIP sense and short interfering RNA (siRNA) vectors in an attempt to establish the upregulation and down-regulation of CacyBP/SIP transfectants. As shown in Fig. 2A and B, CacyBP/SIP was expressed at a higher level in the sense transfectant as compared with the parental and empty vector cells. In contrast, specific siRNAs efficiently down-regulated CacyBP/SIP in the SGC7901 cells at both the protein and mRNA levels, with an inhibitory rate exceeding 85% in the mU6-siCacyBP2 transfectant, as shown by immunofluorescence staining (Fig. 2C) . The mU6-siCacyBP2 and pFLAG-CacyBP transfectants were then used to test the functional outcomes of CacyBP/SIP. In addition, the gastric cancer cell, AGS, which endogenously expresses CacyBP/SIP protein at a relatively lower level was transfected with pFLAG-CacyBP plasmid to obtain the CacyBP/SIPoverexpressed AGS cells (Fig. 2D ).
Growth Inhibition of Gastric Cancer Cells by CacyBP/SIP Protein
The proliferation of the transfected cells was shown by the methyl thiazolyl tetrazolium (MTT) assay and cell count method. Both results showed that siRNA-transfected SGC7901 cells (SGC7901-siCacyBP) proliferated at a faster rate than did control cells (SGC7901-mU6; P < 0.01), whereas SGC7901-CacyBP and AGS-CacyBP cells with a higher expression of CacyBP/SIP exhibited a greater reduction in the proliferative rate than in control and parental cells (P < 0.01; Fig. 3 ). Our data suggest that the growth of gastric cancer cells was negatively correlated with the level of expression of CacyBP/SIP.
Inhibition of Tumorigenicity of Gastric Cancer Cells In vitro and In vivo by Up-Regulation of CacyBP/SIP
The clonogenic assay is an effective method to evaluate the proliferative ability and tumorigenicity of a single cell in vitro. Therefore, we applied the plate and soft agar clonogenic assays to investigate the role of CacyBP/SIP in the development of gastric cancer. As shown in Fig. 4A , B, and C, the forced overexpression of CacyBP/SIP dramatically reduced the number and size of surviving colonies from the two gastric cancer cell lines compared with the empty vector -transfected control cells, whereas SGC7901-siCacyBP cells showed a notably increased plating efficiency compared with the controls (parental cell and SGC7901-mU6 cell). To confirm this effect in vivo, we injected transfected SGC7901 cells into the cervical hypodermis of nude mice. It was found that tumor formation occurred in all groups, but the tumor volumes of the mice injected with SGC7901-CacyBP cells were smaller than in the control groups (Fig. 4D ). In addition, the survival time was 89.67 F 9.50 days for the SGC7901-CacyBP -injected mice, which was markedly longer than in the mice injected with SGC7901-pFLAG (68.67 F 3.05 days; P < 0.01). In contrast, the mice injected with SGC7901-siCacyBP had a significantly shorter survival time (50.33 F 3.51 days) compared with the control SGC7901-mU6 (75.33 F 8.51 days; P < 0.01). The in vivo results were in good agreement with the results obtained in the in vitro clonogenic assay. To confirm that the effects of CacyBP/SIP protein expression on xenograft growth were caused by the proliferation potential of transfected cells, but not because of increased angiogenesis contributing to the xenograft tumor growth, we performed immunohistochemical analyses on various tumor sections to assess angiogenesis in mice. As shown in Fig. 4E , the microvessel densities in the xenografts were 14.3 F 4.5 (SGC7901), 16.3 F 4.9 (SGC7901-pFLAG), 17.3 F 3.8 (SGC7901-CacyBP), 15.3 F 3.2 (SGC7901-mU6), and 17.7 F 1.5 (SGC7901-siCacyBP), and statistical analysis showed no significant difference between the groups, suggesting the CacyBP/SIP protein in gastric cancer cells did not influence angiogenesis in the xenografts. Taken together, these results implied that CacyBP/SIP plays a suppressive role and may partly reverse the malignant growth potential of gastric cancer cells both in vitro and in vivo.
Impairment of Invasion Potential of Gastric Cancer Cells by CacyBP/SIP Expression
To see if the different levels of expression of CacyBP/SIP might have an effect on invasion potential, the Matrigel-coated transwell assay was used to detect the invasive activity of the transfectants. As shown in Fig. 5 , compared with control cells, the number of SGC7901-siCacyBP cells that succeeded in invading the Matrigel was significantly increased, with a relative invasion index of 4.06 F 0.036 (P < 0.001). Conversely, the relative invasion indices of SGC7901-CacyBP and AGS-CacyBP cells were 0.1919 F 0.067 and 0.45 F 0.09, respectively, which was markedly lower than the corresponding control cells. These data indicated that CacyBP/SIP may impair the invasive capacity of gastric cancer cells, and thus, might inhibit tumor progression and metastasis.
The Expression of b-Catenin in Transfectants
Because CacyBP/SIP is involved in h-catenin degradation as a component of the ubiquitin ligase complex, we determined the h-catenin expression in all transfectants to confirm the effect of CacyBP/SIP on h-catenin and to evaluate the possible mechanism by which CacyBP/SIP affects the malignant phenotype of gastric cancer cells. It was shown that the total h-catenin protein levels increased greatly in SGC7901-siCacyBP cells by Western blot analysis and reduced the level of expression in SGC7901-CacyBP, although no change occurred in the mRNA ( Fig. 6A and B) in these cells. As a transcription factor, h-catenin only performs transcriptional functions when it is translocated into the nucleus, so we further investigated the levels of nuclear h-catenin protein using Western blot analysis and immunofluorescence staining. As shown in Fig. 6C , a greater amount of nuclear h-catenin in the siRNA transfectant was detected and lower nuclear h-catenin levels existed in SGC7901-CacyBP cells compared with control cells. Immunofluorescence staining of nuclear h-catenin in SGC7901-siCacyBP cells was significantly stronger than in control cells (Fig. 6D ), in accordance with the results of the Western blot analysis. Because h-catenin is required as a cofactor for the activation of the transcription factor, Tcf/LEF, we determined the effects of CacyBP/SIP on Tcf/LEF activity in the gastric cancer cell, SGC7901, using transient transfection reporter gene assays. When the siRNA plasmid, mU6-siCacyBP, was cotransfected, Tcf/LEF activity was increased (Fig. 6E ). Transfecting greater amounts of mU6-siCacyBP plasmid further raised Tcl/LEF activity in a dose-dependent manner. In contrast, the overexpression-regulation of CacyBP/ SIP resulted in reduced h-catenin -mediated activation of Tcf/ LEF. Taken together, we inferred that CacyBP/SIP might participate in regulating the malignant behavior of gastric cancer cells in part by modulating h-catenin expression and Tcf/ LEF activity. Discussion S100 protein is the biggest subfamily in calcium-binding proteins with EF-hands. It has also been shown that S100 proteins are associated with cell cycle progression, differentiation, metabolism (17) , and metastatic phenotype (18) . These proteins always function by interacting with their targets. CacyBP/SIP is a new target that binds to S100A6, S100A1, S100A12, S100B, and S100P in a Ca 2+ -dependent manner (3). It has been reported that CacyBP/SIP may be involved in the differentiation of erythroid cells and neurons, and plays a role in thymocyte development by affecting the level of h-catenin (6). However, the pathologic roles of CacyBP/SIP, as a target for S100 proteins that participate in the development and progression of numerous tumors and diseases, remain unclear. To better elucidate the function of CacyBP/SIP, we investigated the effect of this molecule on the behavior of gastric cancer cells.
CacyBP/SIP has been reported to be differentially expressed in various normal tissues of the rat and human neuron cell lines. In the present study, we characterized CacyBP/SIP expression at the mRNA and protein levels in six gastric cancer cell lines and showed that it was expressed at different levels and that the level of expression was positively correlated with the differentiation status of the gastric cancer cells. Many studies have shown that poorly differentiated tumors have an increased growth rate and unfavorable prognosis (19, 20) , indicating that the level of expression of CacyBP/SIP may be associated with the growth of gastric cancer cells.
To further explore the regulatory effect of CacyBP/SIP on the malignant phenotype of gastric cancer cells, we established CacyBP/SIP-overexpressing and knockdown sub -cell lines using gene transfection. Our investigation on the behavior of these transfectants showed that a higher level of expression of CacyBP/SIP inhibited cell proliferation. On the contrary, reduction of CacyBP/SIP expression with RNA interference promoted cell growth, which was in accordance with the findings by Fukushima et al. (6) , that CacyBP/SIP-deficient mouse embryonic fibroblasts had a faster growth rate and showed enhanced proliferation properties. Furthermore, the overexpression of CacyBP/SIP suppressed the tumorigenicity of gastric cancer cells in vitro and relieved tumor malignant behavior in nude mice, whereas inhibition of CacyBP/SIP yielded the opposite effects. Taken together, the data suggested that CacyBP/SIP may be a growth suppression molecule that acts directly or indirectly to control the proliferation of gastric cancer cells and induces a reversal of the malignant phenotype.
Cell migration is a prerequisite for cancer invasion and metastasis. Many members of the EF-hand calcium sensor family play an important role in regulating tumor cell invasiveness (21, 22) . In some cases, the level of S100A6 expression correlates with high metastatic activity, suggesting its involvement in increased cell invasion (23) . S100A4 has also been shown to regulate cell motility and invasion to promote cancer metastasis (24) . In our present study, we found that the overexpression of CacyBP/SIP, a target for the calcium-binding S100 protein family, led to decreased invasive ability. Conversely, the siRNA-mediated CacyBP/SIP knockdown in SGC7901 cells was characterized by the increased invasive potential of cells. Therefore, CacyBP/SIP is proposed to be involved in the invasion and metastatic processes of gastric cancer. However, the mechanism by which CacyBP/SIP reduces cell invasiveness remains to be identified.
What mechanism might be responsible for the suppression of malignant behavior of gastric cancer cells by CacyBP/SIP? It has been reported that CacyBP/SIP binds Siah-1 and Skp1, which are components of the ubiquitin ligase that regulates h-catenin degradation (9, 25, 26) . h-Catenin is normally maintained at low levels due to its constitutive proteasomal degradation (27) . Once the degradation of h-catenin is repressed (e.g., inhibition of GSK3h kinase activity), h-catenin accumulation results in its translocation into the nucleus and interaction with Tcf/LEF family transcription factors to activate the expression of target genes important for cell proliferation, such as c-myc and cyclin D1 (28) . The h-catenin -dependent oncogenic signaling network is involved in the multistep process of tumorigenesis, including cell proliferation (29) , invasion (30) , and inhibition of apoptosis (31) . The results in our study showed that the inhibition of CacyBP/SIP protein increased the expression of h-catenin without a change in the mRNA level in gastric cancer cells, suggesting that CacyBP/SIP may be a critical component required in the h-catenin ubiquitin-degradation pathway. In addition, the expression of h-catenin in nuclei increased and the transcriptional activity of Tcf/LEF was enhanced in conjunction with reduced CacyBP/SIP. We suspect that CacyBP/SIP may suppress the malignant phenotype of gastric cancer cells in part by affecting the expression of h-catenin and the activity of Tcf/LEF.
In conclusion, we studied the biological role of CacyBP/SIP in gastric cancer and observed that overexpression of CacyBP/ SIP could inhibit the proliferation and invasive potential of SGC7901 cells, suggesting a tumor suppressor function for CacyBP/SIP by affecting the expression of h-catenin and transcriptional activity of Tcf/LEF.
Materials and Methods
Cell lines and Animals
The gastric cancer cell lines, SGC7901 and MGC803 (Academy of Military Medical Sciences), AGS and KATO III (American Type Culture Collection), and MKN45 and MKN28 (Riken) were perpetuated in our institute. These cell lines were cultivated in RPMI 1640 (Life Technologies) supplemented with 10% heat-inactivated FCS, penicillin (100 units/mL), and streptomycin (100 Ag/mL) in a CO 2 incubator (Forma Scientific). BALB/c nude mice, 4 to 6 weeks old, were provided by the Shanghai Cancer Institute (Shanghai, China) for the in vivo tumorigenicity study. The mice were maintained in a laminar airflow cabinet under specific pathogen -free conditions, housed in cages, and provided with sterile food and water ad libitum. The experiments were performed along established, institutional animal welfare guidelines concordant with NIH species criteria.
Semiquantitative RT-PCR
To examine the mRNA level of CacyBP/SIP in gastric cancer cells, we did RT-PCR amplification on RNA extracted from gastric cancer cells using specific primers for CacyBP/SIP (accession AF_314752). Briefly, the total RNA was converted to cDNA by oligo(dT) 18 primer and M-MuLV reverse transcriptase. The specific primers for CacyBP/SIP were as follows: 5 ¶-cgaatatggcttcagaagagcta-3 ¶ (sense) and 5 ¶-tcaaaattccgtgtctcctttg-3 ¶ (antisense). The PCR conditions were as follows: 5 min at 94jC for a hot start, followed by 25 cycles of 45 s at 94jC, 45 s at 60jC, and 60 s at 72jC, with a final extension of 10 min at 72jC. The length of the PCR product was 687 bp. To normalize differences in the amount of cDNA added to the reaction, amplification of h-actin was done as an internal control. The PCR products were separated by 1% agarose gels and stained with ethidium bromide. Quantification of differences in mRNA levels was done using the Kodak Digital Science Electrophoresis Documentation and Analysis System 290 (Eastman Kodak Co.).
Western Blot Analysis
The cells were collected and lysed on ice in a buffer containing 50 mmol/L of Tris-Cl (pH 7.5), 150 mmol/L of NaCl, 0.2 mmol/L of EDTA, 1 mmol/L of phenylmethylsulfonyl fluoride, and 1% NP40, then quantified by the Bradford method. The lysates (100 Ag) were electrophoresed in 12% SDS-PAGE and blotted on a nitrocellulose membrane. The membranes were blocked with 10% fat-free milk at room temperature for 2 h and were incubated overnight with primary antibodies at 4jC overnight. After washing thrice for 15 min in TBS supplemented with 0.1% Tween 20, the membranes were incubated with peroxidase-conjugated goat anti-mouse/rabbit IgG antibody (diluted 1:2,000; Amersham-Pharmacia Biotech) for 2 h at room temperature. The membranes were washed again in TBS supplemented with 0.1% Tween 20, and finally in substrate for enhanced chemoluminescence (Amersham) for 5 to 20 min. Exposed X-ray films were scanned for evaluation of the band densities. Primary antibodies included mouse anti-CacyBP/SIP antibody (diluted 1:2,000; prepared in our institute), mouse anti -h-catenin (diluted 1:4,000; Sigma), and mouse anti -h-actin (diluted 1:4,000; Sigma).
Generation of Sense and siRNA of the CacyBP/SIP Eukaryotic Expression Vector
Full-length cDNA encoding human CacyBP/SIP was generated from gastric cancer cells by RT-PCR. The specific primers for CacyBP/SIP were 5 ¶-gggaattcgaatatggcttcagaagagcta-3 ¶ (sense) and 5 ¶-gcgatatctcaaaattccgtgtctcctttg-3 ¶ (antisense). The PCR products were cloned into a pUCm-T vector by a thymineadenine (T-A) cloning technique for further sequencing. Then, cDNA inserts were released from recombinant pUCm-T plasmids by restriction enzyme digestion and subcloned into the eukaryotic expression vector, pFLAG-CMV-3 (Sigma) to achieve the sense vector, pFLAG-CacyBP.
Two siRNAs targeting 118 to 136 (CacyBP-siRNA1) and 301 to 319 (CacyBP-siRNA2) of the CacyBP/SIP coding sequence, respectively, were designed and aligned to the human genome database in a BLAST search to ensure that the chosen sequences were not highly homologous with those of other FIGURE 6 . CacyBP/SIP regulates h-catenin levels and Tcf/LEF activity. A. Total h-catenin mRNA in cells examined by semiquantitative RT-PCR. B. Total h-catenin protein level measured by Western blot analysis. C. The h-catenin expressions in the nuclear protein extract from the cells were tested using Western blot analysis. D. Subcellular distributions of h-catenin in transfectants were determined using immunofluorescence staining. E. Effect of CacyBP/ SIP on Tcf/LEF reporter activity. SGC7901 cells were transiently transfected with a reporter gene plasmid that contains a Tcf/LEF-responsive element cloned upstream of a luciferase reporter gene together with PRL-TK plasmid as a transfection-efficiency control and the indicated plasmids (pFLAG-CMV, pFLAGCacyBP, mU6pro, and mU6-siCacyBP). Luciferase activity was measured in cell lysates 24 h later. *, P < 0.01, cotransfected pFLAG-CacyBP plasmid compared to pFLAG-CMV plasmid; # , P < 0.01, cotransfected mU6-siCacyBP plasmid compared to mU6pro plasmid. These experiments were repeated in triplicate.
genes: for oligo-1; sense, 5 ¶-tttgttgcatcttgttcttgatacaatcaagaacaagatgcaacttttt-3 ¶, and antisense, 5 ¶-ctagaaaaagttgcatcttgttcttgattgtatcaagaacaagatgcaa-3 ¶; and for oligo-2; sense, 5 ¶-tttgcacctgcacattctcagtacaactgagaatgtgcaggtgcttttt-3 ¶, and antisense, 5 ¶-ctagaaaaagcacctgcacattctcagttgtactgagaatgtgcaggtg-3 ¶. The pairs were annealed in annealing buffer [0.1 mol/L NaCl and 10 mmol/L Tris (pH 7.4)] and cloned into the mU6pro vector to construct the siRNA vector of CacyBP/SIP (mU6-siCacyBP). The siRNA vector, mU6pro, was a generous gift from Professor Dave Turner (University of Michigan).
Cell Transfection
Cells were plated and grown to 70% to 90% confluency without antibiotics. Transfections were done with Lipofect-AMINE 2000 (Invitrogen AB), as directed by the manufacturer. The CacyBP/SIP sense vector (pFLAG-CacyBP) was introduced into SGC7901 and AGS cells. For stable expression of siRNAs, SGC7901 cells were cotransfected with 1 Ag of siRNA-expressing vectors (mU6-siCacyBP) and 100 ng of pcDNA3.1(+) plasmid (Invitrogen). Clones were selected after 2 months of screening with G418. The pFLAG-CMV and mU6pro vectors were transfected into cells as controls. Semiquantitative RT-PCR, Western blot analysis, and immunofluorescence staining were used to examine the expression of CacyBP/SIP in these transfectants.
Immunofluorescence Staining
The transfectants were plated onto cleaned-up coverslips and fixed with 95% alcohol for 20 min at room temperature. The coverslips were washed with PBS and permeabilized for 10 min with 0.5% Triton X-100 in PBS. The cells were incubated with anti-CacyBP/SIP antibody (diluted 1:2,000) or anti -h-catenin antibody (diluted 1:2,000) after blocking with 3% bovine serum albumin for 1 h. The cells were then incubated with FITCconjugated anti-mouse IgG (Santa Cruz Biotech). The immunofluorescence was analyzed under a MRC-1024 Laser Scanning Confocal Imaging System (Bio-Rad).
Cell Growth Assay
The proliferation of cells was evaluated by the cell-counting method and the MTT assay (32) . Cells (2 Â 10 4 per well) were seeded in 12-well plates and allowed to grow for different times. The growth rate was determined by the cell number, counted on a hemacytometer in triplicate every day of the culture, up to the 7th day. For the MTT assay, cells were plated in a 96-well plate at 2.5 Â 10 3 cells/well. For 7 days, cells were incubated with 50 AL of 0.2% MTT for 4 h at 37jC in a 5% CO 2 incubator. Following MTT incubation, 150 AL of 100% DMSO was added to dissolve the crystals. Viable cells were counted every day by reading the absorbance at 490 nm using a 96-plate reader BP800 (Dynex Technologies).
Clonogenic Assay
To measure the proliferative ability of a single cell in vitro, plate clonogenic (33) and soft agar clonogenic assays (34) were done. For the plate clonogenic assay, 1 Â 10 3 cells were seeded into a 9-cm dish and cultured in RPMI 1640 for 2 weeks to allow colony formation. Colonies were fixed in 70% ethanol, stained with Giemsa solution, and counted. For the soft agar clonogenic assay, the cells were detached and plated in 0.3% agarose with a 0.5% agarose underlay (1 Â 10 3 /well in a 24-well plate). The number of foci >100 Am was counted after 20 days.
Tumor Growth in Nude Mice
The logarithmically growing cells (1 Â 10 7 ) were trypsinized and resuspended in 0.1 mL of D'Hanks solution, and injected into the cervical hypodermis of athymic nude mice. The tumor growth was observed and the survival time of the mice was recorded from the day of injection. The size of the subcutaneous tumor mass was measured by calipers for 5 weeks. Tumor volume was calculated according to the formula: 0.5 Â length Â width 2 . Each experimental group consisted of five mice.
Immunohistochemical Staining
The avidin-biotin complex immunoperoxidase method (34) was used to examine the microvessel density of xenograft tissues. In brief, the slides were blocked in 10% normal goat serum for 1 h. The slides were then incubated with anti-factor VIII -related antigen (FVIIIRAg) primary antibody (polyclonal rabbit anti-FVIIIRAg antibody diluted at 1:200; Beijing Biosynthesis Biotechnology Co.) at 4jC overnight and washed thrice in PBS for 5 min. The tissues were incubated in biotinlabeled goat anti-rabbit IgG (diluted 1:200) for 30 min, rinsed with PBS, and incubated with avidin-biotin-peroxidase complex for 1 h. The signal was detected using 3,3-diaminobenzidine as the chromogen. Microvessel density was quantified by examining areas of vascular hotspots, as previously described by Weidner et al. (35) . Sections were scanned at a low magnification (Â40 and Â100) for the localization of vascular hotspots. The three most vascular areas of the tumor not containing necrosis were determined and then counted in a high-power field (Â200). The values of the three sections were averaged and the results were analyzed. Branching structures were counted as a single vessel.
Invasion Assay
A transwell plate (Costar) precoated with Matrigel (Becton Dickinson) was used to perform the cell invasion assay (34) . Briefly, cells were suspended in 0.2 mL of culture medium with 1% FCS and were added to the upper chamber. Ten percent of FCS in the culture medium was plated in the lower chamber as a chemoattractant. Cells in the invasion chambers were incubated in a humidified incubator for 24 h. The cells that traversed the membrane pore and spread to the lower surface of the filters were stained with 5% Giemsa solution for visualization.
Detection of Nuclear b-Catenin Protein
The cells were collected and washed with PBS, then resuspended in buffer A solution [10 mmol/L HEPES-NaOH (pH 7. The nuclear protein extracts were purified and existed in the supernatant after centrifugation at 12,000 Â g for 4 min at 4jC. The extracted nuclear proteins were quantified by the Bradford method and processed for Western blot analysis.
Reporter Gene Assay
To assay the effect of CacyBP/SIP on the transcriptional activity of Tcf/LEF, the reporter gene assay was done as described (36) . Briefly, SGC7901 cells in a 24-well plate (50,000 cells per well) were cotransfected with or without pFLAG-CMV, FLAG-CacyBP, mU6pro, mU6-siCacyBP, and the reporter plasmid, pTOPFLASH, containing wild-type Tcf/ LEF binding sites using LipofectAMINE 2000; pRL-TK Renilla luciferase reporter served as a control for transfection efficiency. The luciferase activity was measured and quantitated in a luminometer using the Dual-Luciferase Reporter Assay System (Promega). Experiments were done in triplicate and repeated twice. Results are expressed as the mean of the ratio between the firefly luciferase activity and the renilla luciferase activity.
Statistical Analysis
Data were analyzed by one-way ANOVA followed by the S-N-K test, using SPSS software package. The Mann-Whitney test was used to compare survival times in the in vivo experiments. For all comparisons, probability values <5% (P < 0.05) were considered statistically significant.
